Sheriza Baksh

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma”.

Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma

medRxiv(2021)10.1101/2021.12.10.21267485

N/A

1.4DataRank · unranked

38 citations

Kelly A. Gebo, Shmuel Shoham, Evan M. Bloch, Bryan Lau, Aarthi Shenoy +53 more

Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection

medRxiv(2021)10.1101/2021.12.13.21267611

N/A

0.507DataRank · unranked

10 citations

Evan M. Bloch, Arturo Casadevall, Daniel F. Hanley, Bryan Lau, Kelly A. Gebo +50 more

Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial

JCI Insight(2024)10.1172/jci.insight.178460

N/A

0.427DataRank · unranked

12 citations

Anna Yin, Caelan Barranta, John S. Lee, Christopher Caputo, Jaiprasath Sachithanandham +76 more

Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial

medRxiv(2023)10.1101/2023.04.13.23288353

N/A

0.104DataRank · unranked

1 citations

Anna Yin, Caelan Barranta, John S. Lee, Christopher Caputo, Jaiprasath Sachithanandham +76 more

Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis

Medicine(2023)10.1097/md.0000000000033904

N/A

0DataRank · unranked

3 citations

Malathi Ram, Daniel O. Scharfstein, Tianjing Li, P Khanal, Sheriza Baksh +13 more

Early Treatment, Inflammation and Post-COVID Conditions

medRxiv(2023)10.1101/2023.02.13.23285855

N/A

0DataRank · unranked

5 citations

Sonya L. Heath, Yuriko Fukuta, Xianming Zhu, Sheriza Baksh, Alison G. Abraham +38 more

Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort study

Scientific Reports(2021)10.1038/s41598-021-95687-z

N/A

0DataRank · unranked

7 citations

Jiajun Wen, Omar Mansour, Hsien‐Yen Chang, Mara McAdams‐DeMarco, Jodi B Segal +3 more

Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial

Ophthalmology(2025)10.1016/j.ophtha.2025.10.004

N/A

0DataRank · unranked

7 citations

Elizabeth A. Sugar, Alyce Burke, Michael M. Altaweel, Jennifer E. Thorne, Sheriza Baksh +5 more

Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis

PLoS ONE(2022)10.1371/journal.pone.0273526

N/A

0DataRank · unranked

11 citations

Elizabeth L. Ogburn, Malathi Ram, Daniel O. Scharfstein, Tianjing Li, P Khanal +23 more

Early antibody treatment, inflammation, and risk of post-COVID conditions

mBio(2023)10.1128/mbio.00618-23

N/A

0DataRank · unranked

22 citations

Sonya L. Heath, Yuriko Fukuta, Xianming Zhu, Sheriza Baksh, Allison G. Abraham +38 more

Transfusion reactions associated with COVID‐19 convalescent plasma in outpatient clinical trials

Transfusion(2023)10.1111/trf.17485

N/A

0DataRank · unranked

11 citations

Jay S. Raval, James H. Paxton, Giselle Mosnaim, Bela Patel, Shweta Anjan +53 more